Bhardwaj Nitin, Ahmed Md Zohaib, Sharma Supriya, Nayak A, Anvikar Anupkumar R, Pande Veena
ICMR-National Institute of Malaria Research, New Delhi; Department of Biotechnology, Kumaun University, Bhimtal, Uttarakhand, India.
ICMR-National Institute of Malaria Research, New Delhi, India.
J Vector Borne Dis. 2019 Apr-Jun;56(2):122-126. doi: 10.4103/0972-9062.263727.
BACKGROUND & OBJECTIVES: Plasmodiumfalciparum malaria causes wide variety of clinical symptoms ranging from a mild febrile illness to life-threatening complications. For prevention of the severity and early diagnosis, evaluation of potential biomarkers is much needed. C-reactive protein (CRP) is an acute phase protein and well-recognized marker of inflammation in the body. It is synthesized by liver in response to pro-inflammatory responses and has correlation with complications associated with malaria. The study was aimed to assess, if it could serve as a predictive marker for malaria disease severity.
In the present study, 74 P. falciparum patients and 22 healthy controls were enrolled. Turbidimetric immunoassay was used to measure the CRP in serum samples of all the study participants. Mann-Whitney U-test for continuous data and chi-square test for categorical data were used to compare all malaria cases vs. healthy control group and uncomplicated vs. severe malaria groups. Using receiver operating characteristic (ROC) analysis, best threshold value was determined for CRP in severe malaria patients.
CRP level was significantly elevated in all malaria case groups (1.6 mg/dl IQ 1-2.6) as compared to healthy controls (0.10 mg/dl IQ 0.1-0.20), with p-value <0.0001. Further, CRP level was significantly higher in the severe malaria group (2 mg/dl IQ 1.8-3.9) as compared to the uncomplicated malaria group (1.4 mg/dl IQ 1-2.47) and healthy control group (0.10 mg/dl IQ 0.10-0.20), with p-value <0.05.
INTERPRETATION & CONCLUSION: The present study findings suggest that CRP level can be used to differentiate severe malaria from uncomplicated malaria. Elevated CRP level could be helpful in early prediction of the disease severity in patients infected with P. falciparum and may play an important role in diagnosis of falciparum malaria where improper initial test and clinical manifestations like fever may be absent even with a high load of parasite.
恶性疟原虫疟疾可引发多种临床症状,从轻症发热疾病到危及生命的并发症。为预防疾病严重程度并实现早期诊断,急需评估潜在的生物标志物。C反应蛋白(CRP)是一种急性期蛋白,是体内炎症的公认标志物。它由肝脏在促炎反应时合成,与疟疾相关并发症存在关联。本研究旨在评估其是否可作为疟疾疾病严重程度的预测标志物。
在本研究中,纳入了74例恶性疟原虫患者和22名健康对照。采用比浊免疫分析法测定所有研究参与者血清样本中的CRP。连续数据采用曼-惠特尼U检验,分类数据采用卡方检验,以比较所有疟疾病例与健康对照组以及非重症与重症疟疾组。使用受试者工作特征(ROC)分析确定重症疟疾患者CRP的最佳阈值。
与健康对照组(0.10mg/dl,四分位数间距0.1 - 0.20)相比,所有疟疾病例组的CRP水平显著升高(1.6mg/dl,四分位数间距1 - 2.6),p值<0.0001。此外,与非重症疟疾组(1.4mg/dl,四分位数间距1 - 2.47)和健康对照组(0.10mg/dl,四分位数间距0.10 - 0.20)相比,重症疟疾组的CRP水平显著更高(2mg/dl,四分位数间距1.8 - 3.9),p值<0.05。
本研究结果表明,CRP水平可用于区分重症疟疾与非重症疟疾。CRP水平升高有助于早期预测恶性疟原虫感染患者的疾病严重程度,在恶性疟的诊断中可能发挥重要作用,因为在初始检测不当且存在发热等临床表现时,即便寄生虫载量高也可能不存在这些症状。